Dual biological therapy and small molecules in pediatric inflammatory bowel disease-Reference-Cited by-同舟云学术

Dual biological therapy and small molecules in pediatric inflammatory bowel disease

Published:2023-10 Issue: Volume:196 Page:106935
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Penagini Francesca^ORCID,Lonoce Luisa,Abbattista Luisa,Silvera Valentina,Rendo Giulia,Cococcioni Lucia,Dilillo Dario,Calcaterra Valeria,Zuccotti Gian Vincenzo

Publisher

Elsevier BV

Subject

Pharmacology

Reference81 articles.

1. Ustekinumab for resistant pediatric crohn disease;Rinawi;J. Pediatr. Gastroenterol. Nutr.,2016

2. Diagnosis and management of inflammatory bowel disease in children;Oliveira;BMJ,2017

3. Natural history of Crohn's disease: Comparison between childhood- and adult-onset disease;Pigneur;Inflamm. Bowel. Dis.,2010

4. Inflammatory bowel disease in children and adolescents;Rosen;JAMA Pediatr.,2015

5. Crohn's disease;Baumgart;Lancet,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnoflorine alleviates dextran sulfate sodium‐induced ulcerative colitis via inhibiting JAK2/STAT3 signaling pathway;Phytotherapy Research;2024-07-30

2. Updates In The Management Of Pediatric Inflammatory Bowel Disease;Canadian IBD Today;2024-06-05

3. Genotype and clinical phenotype of children with Marfan syndrome in Southeastern Anatolia;European Journal of Pediatrics;2024-05-03

4. STEP-CD study: ustekinumab use in paediatric Crohn’s disease—a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN;European Journal of Pediatrics;2024-05-03

5. Identification of Disulfidptosis-Related Genes in Ulcerative Colitis;2024